Your browser doesn't support javascript.
loading
Evaluation of disease-free survival as an intermediate metric of overall survival in patients with localized renal cell carcinoma: A trial-level meta-analysis.
Harshman, Lauren C; Xie, Wanling; Moreira, Raphael B; Bossé, Dominick; Ruiz Ares, Gustavo J; Sweeney, Christopher J; Choueiri, Toni K.
Afiliação
  • Harshman LC; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Xie W; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Moreira RB; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Bossé D; Oncoclinic Group, Alemao Oswaldo Cruz Hospital, Sao Paulo, Brazil.
  • Ruiz Ares GJ; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Sweeney CJ; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Choueiri TK; Department of Clinical Oncology, University Hospital 12 de Octubre, Madrid, Spain.
Cancer ; 124(5): 925-933, 2018 03 01.
Article em En | MEDLINE | ID: mdl-29266178
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Clinical_trials / Guideline / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Clinical_trials / Guideline / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article